Effectiveness of low-dose atropine and combination with bright light therapy for controlling myopic eye growth in schoolchildren: study protocol for a randomised controlled trial (Preprint)
JMIR Research Protocols · 2026
DOI: 10.2196/90893 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2026. Verfasst von Dennis Yan-Yin Tse und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for SHARP Vision, The Hong Kong Polytechnic University, Hong Kong, China (Hong Kong). Hauptthemen laut MEDLINE: Atropine, Myopia, Phototherapy. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Myopia is increasingly prevalent worldwide, with projections indicating that nearly 50% of the global population may have myopia by 2050. This surge poses significant concerns due to its impact on vision and quality of life and its link to a range of blinding diseases, including myopic macular degeneration, glaucoma, and retinal detachment. Current pharmacologic and optical interventions offer limited effectiveness in slowing myopia progression, highlighting the urgent need for more effective treatments.
Objective
This study aims to examine the combined effect of bright light therapy and low-dose atropine on myopic progression.
Methods
This is a single-site, 2-arm, single-masked (examiner-masked) randomized controlled trial to compare the effectiveness of low-dose atropine alone and its combination with bright light therapy in retarding myopia progression. The study protocol has been approved by the institutional review boards of Hong Kong Polytechnic University (HSEARS 20180829002-05) and the University of Hong Kong and Hospital Authority Hong Kong West Cluster (UW 20-362). Schoolchildren with myopia aged 7 to 12 years who have not undergone any previous myopic control intervention will be recruited and randomly allocated into 2 groups (n=67 per group) after baseline measurements. Both groups will receive 0.01% atropine twice daily for 24 months. The combination treatment group will also receive a high-intensity lamp for bright light therapy. The primary and secondary outcome measures will be the changes in cycloplegic autorefraction in spherical equivalent refraction and axial length, respectively, measured every 6 months over 2 years from baseline.
Results
The project was funded in January 2019. The recruitment process started on March 21, 2023, and was completed on February 2, 2024. Data collection is expected to be completed in April 2026.
Conclusions
This study will provide new information on whether the combination of bright light therapy and low-dose atropine is more effective than atropine alone in slowing down myopia progression. It will also assess the effectiveness of low-dose atropine used twice daily. Combining bright light therapy and atropine could become a new treatment option if shown to be effective. New data on the effectiveness of using atropine twice daily might also expand available treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for SHARP Vision, The Hong Kong Polytechnic University, Hong Kong, China (Hong Kong).
- InnoHK, Centre for Eye and Vision Research, 17W Hong Kong Science Park, Hong Kong, China (Hong Kong).
- Centre for Myopia Research, School of Optometry, The Hong Kong Polytechnic University, 11 Yuk Choi Rd, Hung Hom, Kowloon, China (Hong Kong), 852 27666096.
- Vancouver Coastal Health Research Institute, Vancouver, Canada.
- School of Public Health, The University of Hong Kong, Hong Kong, China (Hong Kong).
- Department of Ophthalmology, The University of Hong Kong, Hong Kong, China (Hong Kong).
ORCID-Profile: Dennis Yan-Yin Tse, Martin Ming-Leung Ma, Ying Hon, Lai Ming Ho, Wai Ching Lam, Kendrick Co Shih, Xiujuan Zhang, Desmond Man Kit Lam, Andy Chi Wai Kong, Thomas Chuen Lam, Carly Siu Yin Lam, Tina Jinxiao Lian, Ian Morgan, Chi Ho To, Rachel Ka Man Chun, Christopher Kai Shun Leung
Zitieren
APA
Tse, D. Y., Ma, M. M., Hon, Y., Ho, L. M., Lam, W. C., Shih, K. C., Zhang, X., Lam, D. M. K., Kong, A. C. W., Lam, T. C., Lam, C. S. Y., Lian, T. J., Morgan, I., To, C. H., Chun, R. K. M., & Leung, C. K. S. (2026). Effectiveness of low-dose atropine and combination with bright light therapy for controlling myopic eye growth in schoolchildren: study protocol for a randomised controlled trial (Preprint). JMIR Research Protocols. https://doi.org/10.2196/90893
Vancouver
Tse DY, Ma MM, Hon Y, Ho LM, Lam WC, Shih KC, et al. Effectiveness of low-dose atropine and combination with bright light therapy for controlling myopic eye growth in schoolchildren: study protocol for a randomised controlled trial (Preprint). JMIR Research Protocols. 2026. doi:10.2196/90893
BibTeX
@article{Tse2026,
author = {Tse, Dennis Yan-Yin and Ma, Martin Ming-Leung and Hon, Ying and Ho, Lai Ming and Lam, Wai Ching and Shih, Kendrick Co and Zhang, Xiujuan and Lam, Desmond Man Kit and Kong, Andy Chi Wai and Lam, Thomas Chuen and Lam, Carly Siu Yin and Lian, Tina Jinxiao and Morgan, Ian and To, Chi Ho and Chun, Rachel Ka Man and Leung, Christopher Kai Shun},
title = {Effectiveness of low-dose atropine and combination with bright light therapy for controlling myopic eye growth in schoolchildren: study protocol for a randomised controlled trial (Preprint)},
journal = {JMIR Research Protocols},
year = {2026},
doi = {10.2196/90893}
}
EUVIMED